1. CMU Intellectual Repository

Browsing by Author David M. Burger

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)
1-Jan-2020Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate MonotherapyVera E. Bukkems; Elise J. Smolders; Gonzague Jourdain; David M. Burger; Angela P. Colbers; Tim R. Cressey
1-May-2019Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk; Rob Ter Heine; Angela Colbers; Edmund Capparelli; Brookie M. Best; Tim R. Cressey; Rick Greupink; Frans G.M. Russel; José Moltó; Mark Mirochnick; Mats O. Karlsson; David M. Burger
1-Apr-2015Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapyStephen J. Kerr; Baralee Punyawudho; Narukjaporn Thammajaruk; Angela Colbers; Prachya Chaiyahong; Supalak Phonphithak; Vorapot Sapsirisavat; Kiat Ruxrungtham; David M. Burger; Anchalee Avihingsanon
1-Jun-2015Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Baralee Punyawudho; Thitima Pengsuparp
24-May-2019Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patientsNoppaket Singkham; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Torsak Bunupuradah; Sasisopin Kiertiburanakul; Ploenchan Chetchotisakd; David M. Burger; Sean Emery; Baralee Punyawudho
8-Mar-2018A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant WomenStein Schalkwijk; Rob Ter Heine; Angela C. Colbers; Alwin D.R. Huitema; Paolo Denti; Kelly E. Dooley; Edmund Capparelli; Brookie M. Best; Tim R. Cressey; Rick Greupink; Frans G.M. Russel; Mark Mirochnick; David M. Burger
1-Dec-2021ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L. Moore; Anna Turkova; Hilda Mujuru; Adeodata Kekitiinwa; Abbas Lugemwa; Cissy M. Kityo; Linda N. Barlow-Mosha; Tim R. Cressey; Avy Violari; Ebrahim Variava; Mark F. Cotton; Moherndran Archary; Alexandra Compagnucci; Thanyawee Puthanakit; Osee Behuhuma; Yacine Saϊdi; James Hakim; Pauline Amuge; Lorna Atwine; Victor Musiime; David M. Burger; Clare Shakeshaft; Carlo Giaquinto; Pablo Rojo; Diana M. Gibb; Deborah Ford; Shabinah Ali; Abdel Babiker; Chiara Borg; Anne Marie Borges Da Silva; Joanna Calvert; Joshua Gasa; Nasir Jamil; Sarah Lensen; Emma Little; Fatima Mohamed; Samuel Montero; Cecilia L. Moore; Rachel Oguntimehin; Anna Parker; Reena Patel; Tasmin Phillips; Tatiana Sarfati; Karen Scott; Moira Spyer; Margaret Thomason; Rebecca Turner; Nadine Van Looy; Ellen White; Kaya Widuch; Helen Wilkes; Ben Wynne; Tiziana Grossele; Daniel Gomez-Pena; Davide Bilardi; Giulio Vecchia; Yacine Saidi; Yoann Riault; Alexandra Coelho; Laura Picault; Christelle Kouakam; Suwalai Chalermpantmetagul; Dujrudee Chinwong; Gonzague Jourdain; Rukchanok Peongjakta; Pra ornsuda Sukrakanchana; Wasna Sirirungsi; Janet Seeley; Sarah Bernays; Magda Conway; Nigel Klein; Eleni Nastouli; Anita De Rossi; Maria Angeles Munoz Fernandez; David Burger; Pauline Bollen; Angela Colbers; Hylke Waalewijn; Elizabeth Kaudha; Annet Nanduudu; Emmanuel Mujyambere; Paul Ocitti Labeja; Charity Nankunda; Juliet Ategeka; Peter Erim; Collin Makanga; Esther Nambi; Edridah Keminyeto; Deogratiuos Tukwasibwe; Shafic Makumbi; Emily Ninsiima; Mercy Tukamushaba; Rogers Ankunda; Ian Natuhurira; Miriam Kasozi; Baker Rubinga; Adeodata R. Kekitiinwa; Dickson Bbuye; Justine Nalubwama; Winnie Akobye
1-Aug-2019Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIVHylke Waalewijn; Anna Turkova; Natella Rakhmanina; Tim R. Cressey; Martina Penazzato; Angela Colbers; David M. Burger
1-Nov-2017Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Chonlaphat Sukasem; Baralee Punyawudho
1-Jan-2019Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic reviewMarieke Bierhoff; Elise J. Smolders; Joel Tarning; David M. Burger; Rene Spijker; Marcus J. Rijken; Chaisiri Angkurawaranon; Rose McGready; Nicholas J. White; Francois Nosten; Michèle van Vugt
1-Mar-2014Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bandsDiane E.T. Bastiaans; Silvia Forcat; Hermione Lyall; Tim R. Cressey; Rawiwan Hansudewechakul; Suparat Kanjanavanit; Antoni Noguera-Julian; Christoph Konigs; Jamie R.J. Inshaw; Suwalai Chalermpantmetagul; Yacine Saidi; Alexandra Compagnucci; Lynda M. Harper; Carlo Giaquinto; Angela P.H. Colbers; David M. Burger
1-Jan-2018Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul; Suvaporn Anugulruengkitt; Naruporn Kasipong; Narukjaporn Thammajaruk; Jiratchaya Sophonphan; Torsak Bunupuradah; Tim R. Cressey; Angela Colbers; David M. Burger; Wanatpreeya Phongsamart; Thanyawee Puthanakit; Chitsanu Pancharoen
15-May-2008Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R. Cressey; Hannah Green; Saye Khoo; Jean Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M. Gibb; David M. Burger
1-Jan-2014The role of formulation on the pharmacokinetics of antiretroviral drugsDiane Et Bastiaans; Tim R. Cressey; Herman Vromans; David M. Burger
1-Dec-2016Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patientsBaralee Punyawudho; Noppaket Singkham; Narukjaporn Thammajaruk; Theera Dalodom; Stephen J. Kerr; David M. Burger; Kiat Ruxrungtham
1-Sep-2022What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G. Jacobs; Stef Schouwenburg; Martina Penazzato; Moherndran Archary; Theodore D. Ruel; John van den Anker; David M. Burger; Tim R. Cressey; Elaine J. Abrams; Hermione Lyall; Adrie Bekker; Angela Colbers; David Burger; Tim Cressey; Deborah Hirt; Irja Lutsar; Helen Mcilleron; Joe Standing; Elin Svensson; Elaine Abrams; Pauline Amuge; Mo Archary; Yodit Belew; Brookie Best; Helen Bygrave; Edmund Capparelli; Esther Casas; Diana Clarke; Polly Clayden; Mutsa Dangarembizi; Roberto De Lisa; Paolo Denti; Paul Domanico; Shaffiq Essajee; Lisa Frigati; Carlo Giaquinto; Diana Gibb; Stephanie Hackett; Rohan Hazra; Marc Lallemant; Linda Lewis; Shahin Lockman; Imelda Mahaka; Betsy McFarland; Cathal Meere; Fatima Mir; Mark Mirochnick; Lynne Mofenson; Irene Mukui; Angela Mushavi; Victor Musiime; Eleanor Namusoke-Magongo; Elisabeth Obimbo; Mary Atieno Ojoo; Roger Parades; Carmen Perez-Casas; Manuele Piccolis; Jorge Pinto; Thanyawee Puthanakit; Natella Rakhmanina; Annette Reinisch; Pablo Rojo; Vanessa Rouzier; Ted Ruel; Nadia Sam-Agudu; George Siberry; Teresa Simione; Katie Simon; Vindi Singh; Manjari Solares; Nandita Sugandhi; Mariam Sylla; Ibou Thior; Anna Turkova; Marissa Vicari; Jenny Walsh; Melynda Watkins; Hilary Wolf; Asma Hafiz; Ajay Rangaraj; Meg Doherty; Marco Vitoria
Showing results 1 to 16 of 16